FeesSafety
Pluang+

ICE plans a regulated retail market for Hyperliquid perpetual contracts in the US, pending approval.

Market News
29 Oct 2026, 16:17 WIB
Tokenpost
View Source
Bullish
ICE plans a regulated retail market for Hyperliquid perpetual contracts in the US, pending approval.

Intercontinental Exchange (ICE), which owns the New York Stock Exchange, intends to launch a regulated retail market for Hyperliquid-based perpetual contracts in the US through a partnership with Trade[XYZ]. ICE will operate this market exclusively and build a dedicated retail venue and clearing system on Hyperliquid. The market targets retail traders who must pass identity and anti-money laundering checks, with trading done via US futures commission merchants. Regulatory approval, including for leveraged trading, is still required, and no launch date has been announced yet. This new retail platform will complement ICE's existing institutional futures and clearing services.

ICE's plan for a U.S. Hyperliquid perpetual market comes as 19 of 50 major cryptocurrencies on Pluang rose today. For readers following cryptocurrency markets, here is Pluang's snapshot as of Oct 29, 2026 20:05 WIB: CRV (Curve DAO Token) traded at Rp5.960 with a 1-day change of -2.77% and a typical hold time of 62 days, MANA (Decentraland) was at Rp1.397 down 2.51%, and ONE (Harmony) at Rp23 fell 2.48% with a Pluang order activity showing 71% sell and 29% buy.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
38 minutes ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
38 minutes ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
1 hour ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
1 hour ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App